What is Accipiter Biosciences worth?
$22.0Mlast known valuation
Accipiter Biosciences last raised $13.6M in its Early Stage VC (May 2024).
Free account
See the evidence behind this price
- ·Post-money valuations for all 2 rounds
- ·The complete investor list — 9 names
- ·Watchlist + deal alerts for Accipiter Biosciences
Create free account
No card required
Funding history
2 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| May 2024 | Early Stage VC | $13.6M | ▮ | ▮ |
| Apr 2023 | Seed Round | $650K | ▮ | ▮ |
How Accipiter Biosciences's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Accipiter Biosciences, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- What is Accipiter Biosciences worth?
- Accipiter Biosciences's last known valuation is $22.0M.
- How much has Accipiter Biosciences raised?
- Accipiter Biosciences has raised $13.6M in total funding across 2 recorded rounds.
- When did Accipiter Biosciences last raise?
- Accipiter Biosciences last raised in May 2024 (Early Stage VC), raising $13.6M.